Evaxion Biotech A/s Share Price: EVAX (Evaxion Biotech A/s) Stock Price Today & Updates | INDmoney

Question 1

What is Evaxion Biotech A/s share price today?

Accepted Answer

Evaxion Biotech A/s (EVAX) share price today is {{live_price}}.

Question 2

Can Indians buy Evaxion Biotech A/s shares?

Accepted Answer

Yes, Indians can invest in the Evaxion Biotech A/s (EVAX) from India.

With INDmoney, you can buy Evaxion Biotech A/s at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Evaxion Biotech A/s at zero transaction cost.

Question 3

How can I buy Evaxion Biotech A/s shares from India?

Accepted Answer

It is very easy to buy Evaxion Biotech A/s from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Evaxion Biotech A/s be purchased?

Accepted Answer

Yes, you can buy fractional shares of Evaxion Biotech A/s with INDmoney app.

Question 5

What are the documents required to start investing in Evaxion Biotech A/s stocks?

Accepted Answer

To start investing in Evaxion Biotech A/s, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Evaxion Biotech A/s

Accepted Answer

Today’s highest price of Evaxion Biotech A/s (EVAX) is {{1_rba_end}}.

Today’s lowest price of Evaxion Biotech A/s (EVAX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Evaxion Biotech A/s

Accepted Answer

Today's market capitalisation of Evaxion Biotech A/s EVAX is 14.9M

Question 8

What is the 52 Week High and Low Range of Evaxion Biotech A/s

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Evaxion Biotech A/s is down from its 52 Week High?

Accepted Answer

Evaxion Biotech A/s (EVAX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Evaxion Biotech A/s is up from its 52 Week low?

Accepted Answer

Evaxion Biotech A/s (EVAX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Evaxion Biotech A/s?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Evaxion Biotech A/s

Accepted Answer

Mr. Christian  Kanstrup M.Sc. is the current Chief Executive Officer (CEO) of Evaxion Biotech A/s.

Period	Evaxion Biotech A/s	Index (Russel 2000)
3 Months	-17.81%	0.0%
6 Months	-32.39%	0.0%
1 Year	-69.38%	0.0%
3 Years	-96.73%	-20.3%

Market Capitalization	14.9M
Book Value	$0.23
Earnings Per Share (EPS)	-4.5
Wall Street Target Price	10.85

Profit Margin	0.0%
Operating Margin TTM	-2974.68%

Return On Assets TTM	-74.66%
Return On Equity TTM	-802.8%

Revenue TTM	278.0K
Revenue Per Share TTM	0.07
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-18.8M
Diluted Eps TTM	-4.5
Quarterly Earnings Growth YOY	0.0

Evaxion Biotech A/s (EVAX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs ALNY

Vs VRTX

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.39
EPS Estimate Next Year	-1.37
EPS Estimate Current Quarter	-0.39
EPS Estimate Next Quarter	-0.35

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Evaxion Biotech A/s	-16.24%	-32.39%	-69.38%	-96.73%	-97.34%
Regeneron Pharmaceuticals, Inc.	-12.48%	8.55%	19.49%	82.88%	232.15%
Novo Nordisk A/s	-13.09%	-6.28%	18.91%	138.88%	358.83%
Alnylam Pharmaceuticals, Inc.	6.38%	83.19%	66.02%	36.22%	252.82%
Vertex Pharmaceuticals Incorporated	0.3%	18.97%	30.36%	165.15%	176.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Evaxion Biotech A/s	NA	NA	NA	-1.39	-8.03	-0.75	NA	0.23
Regeneron Pharmaceuticals, Inc.	26.81	26.81	1.38	45.04	0.17	0.08	NA	261.41
Novo Nordisk A/s	39.53	39.53	1.79	3.39	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.38	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.58	0.33	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Evaxion Biotech A/s	Buy	$14.9M	-97.34%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$111.6B	232.15%	26.81	32.04%
Novo Nordisk A/s	Buy	$519.8B	358.83%	39.53	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$35.8B	252.82%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$122.9B	176.17%	32.84	-4.74%

Organization	Evaxion Biotech A/s
Employees	49
CEO	Mr. Christian Kanstrup M.Sc.
Industry	Miscellaneous